Singapore markets close in 7 hours 44 minutes

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (1558.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
12.660-0.340 (-2.62%)
At close: 04:08PM HKT
Currency in HKD

Valuation measures4

Market cap (intra-day) 11.14B
Enterprise value 12.15B
Trailing P/E 5.19
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.64
Price/book (mrq)1.30
Enterprise value/revenue 1.93
Enterprise value/EBITDA 4.43

Trading information

Stock price history

Beta (5Y monthly) 0.19
52-week change 386.25%
S&P500 52-week change 322.38%
52-week high 313.300
52-week low 36.020
50-day moving average 311.339
200-day moving average 38.792

Share statistics

Avg vol (3-month) 32.19M
Avg vol (10-day) 32.27M
Shares outstanding 5653.77M
Implied shares outstanding 6879.97M
Float 8393.71M
% held by insiders 162.72%
% held by institutions 14.58%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 42.89
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 429 Sept 2020
Last split factor 22:1
Last split date 309 Jun 2020

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 31.66%
Operating margin (ttm)42.32%

Management effectiveness

Return on assets (ttm)14.16%
Return on equity (ttm)26.50%

Income statement

Revenue (ttm)6.29B
Revenue per share (ttm)7.15
Quarterly revenue growth (yoy)25.90%
Gross profit (ttm)N/A
EBITDA 3.17B
Net income avi to common (ttm)1.99B
Diluted EPS (ttm)2.440
Quarterly earnings growth (yoy)780.40%

Balance sheet

Total cash (mrq)1.69B
Total cash per share (mrq)1.92
Total debt (mrq)2.61B
Total debt/equity (mrq)32.88%
Current ratio (mrq)1.40
Book value per share (mrq)9.02

Cash flow statement

Operating cash flow (ttm)1.67B
Levered free cash flow (ttm)1.09B